论文部分内容阅读
分子靶向治疗是以肿瘤细胞的特性改变为作用靶点,在发挥抗肿瘤活性的同时,减少对正常细胞的不良反应。近年此类药物在临床实践中取得显著疗效,其有的放矢的治疗方法将妇科肿瘤治疗推向了新阶段。分别对针对表皮生长因子受体家族、以血管生成为靶点的分子靶向治疗以及环氧合酶抑制剂等4种靶向治疗药物在子宫肌瘤、外阴癌、宫颈癌、子宫内膜癌、子宫肉瘤、卵巢癌中的研究现状、应用前景进行总结及展望。
Molecular targeted therapy is based on the change of the characteristics of tumor cells as the target of action, while exerting anti-tumor activity and reducing the adverse reactions to normal cells. In recent years, such drugs have achieved remarkable results in clinical practice, its targeted treatment of gynecological cancer treatment to a new stage. Targeting the epidermal growth factor receptor family, angiogenesis as the target molecular targeted therapy and cyclooxygenase inhibitors and other four kinds of targeted therapies in uterine fibroids, vulvar cancer, cervical cancer, endometrial cancer , Uterine sarcoma, ovarian cancer research status, application prospects and prospects.